Qulab's software, Quleap, utilizes artificial intelligence and quantum computing to automate the process of small molecule drug design, reducing the time required for drug discovery and pre-clinical development. It offers capabilities such as de-novo molecular design, molecular dynamics simulation, and synthesis planning. Quleap can be used on classical computers and is accessible for enterprise and academic use. Qulab aims to revolutionize the pharmaceutical industry by integrating advanced computing technology into the discovery phases of drug development, enhancing the process through artificial intelligence and hardware acceleration.